Related Experiment Video
Updated: May 10, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Polypeptide-based nanocarriers from aqueous ROPISA: Shape-dependent performance in colorectal and breast cancer
Hannah Beauseroy1, Sabina Quader2, Xueying Liu2
1University of Bordeaux, CNRS, Bordeaux INP, LCPO, UMR 5629, F-33600, Pessac, France.
This study introduces a new method for creating worm-like polypeptide nanoparticles using ring-opening polymerization-induced self-assembly (ROPISA). These nanoparticles show promising cellular uptake and in vivo tumor accumulation, advancing nanomedicine for drug delivery.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Polypeptide nanocarriers are crucial for drug delivery.
- The impact of nanocarrier morphology on performance is not well understood.
Purpose of the Study:
- To develop a novel method for synthesizing polypeptide nanocarriers with varying morphologies.
- To compare the cellular uptake and in vivo biodistribution of worm-like versus spherical nanocarriers.
Main Methods:
- Synthesized fluorescent worm-like nanoparticles via one-step aqueous ring-opening polymerization-induced self-assembly (ROPISA) of γ-benzyl-l-glutamate N-carboxyanhydride (BLG-NCA).
- Prepared spherical analogues using solvent displacement.
- Evaluated nanoparticle internalization in CT26 and 4T1 cancer cell lines (2D and 3D spheroids).
- Assessed in vivo biodistribution and tumor accumulation in mouse models.
Main Results:
- Both worm-like and spherical nanoparticles were efficiently internalized by cancer cells.
- Faster uptake was observed in CT26 cells, while higher accumulation occurred in 4T1 cells.
- Nanoparticles penetrated 3D spheroids, with slower diffusion but higher final accumulation in 4T1 spheroids.
- In vivo studies showed prolonged circulation and significant tumor accumulation, particularly in 4T1 tumors.
Conclusions:
- ROPISA of NCA is a versatile platform for creating polypeptide nanocarriers.
- Nanoparticle morphology influences cellular uptake and tumor accumulation dynamics.
- These findings support the development of advanced nanomedicines for targeted drug delivery.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

